Synergistic Potential of Nisin and High-Ozonide Oil in Anti-Cancer Therapy

Understanding Nisin and its Anti-Cancer Mechanisms

Nisin is a naturally occurring antimicrobial peptide produced by the bacteria Lactococcus lactis (L. lactis) found in the gut microbiome of humans and animals. It plays a beneficial role in digestion and immune function. First discovered in the 1920s and subsequently characterized in the 1940s, nisin consists of 34 amino acids, including rare components like lanthionine and dehydroalanine. This peptide is widely used in the dairy industry to produce fermented milk products like cheese and yogurt and as a food preservative due to its remarkable ability to inhibit bacterial growth. The World Health Organization (WHO) approved nisin as a safe substance for human consumption in 1969, and the Food and Drug Administration (FDA) approved it in 1988. Since then, it has been widely used in dairy products, canned foods, and other preserved foodstuffs for over 50 years while showing potential as a therapeutic for various infectious diseases.

Beyond its traditional role in the food industry, nisin’s unique structural properties and selective antimicrobial mechanisms have attracted significant scientific interest from cancer researchers. Recent investigations have revealed its potential as a promising candidate for cancer treatment, combining its established safety profile with newly discovered anti-cancer properties. Research has revealed several sophisticated mechanisms through which nisin exhibits its anti-cancer effects. Cancer cells characteristically display negatively charged phospholipids on their outer membrane surface, unlike normal cells, which maintain these phospholipids on the inner membrane surface. Nisin, being positively charged, selectively targets these exposed negative charges. Nisin’s anti-cancer properties operate through four primary mechanisms:

1. Nisin disrupts membranes by creating pores (tiny holes) in cancer cell membranes that disrupt ion balance and cellular homeostasis. This action shows particular selectivity for cancer cells due to their uniquely negatively charged membrane composition, enabling the influx of calcium and other molecules and destabilizing the cell while largely sparing healthy tissue.
2. It initiates calcium-mediated apoptosis through membrane pores that trigger significant calcium influx, activating calcium-dependent and independent apoptotic pathways. This process works through CHAC1-dependent mechanisms and leads to increased expression of pro-apoptotic proteins, particularly caspase-3, and changes in the BAX/BCL-2 ratio.
3. Nisin regulates the cell cycle by arresting cancer cells, specifically in the G2 phase, effectively preventing them from completing cell division. This cell cycle disruption is particularly effective in aggressive cancers like head and neck squamous cell carcinoma (HNSCC).
4. It disrupts mitochondrial function by altering membrane potential and increasing reactive oxygen species (ROS) levels within cancer cells. This disruption initiates the intrinsic apoptotic pathway while maintaining selectivity for cancer cells.

Note: Recent research has demonstrated that L. lactis, the bacteria responsible for producing nisin, possesses its own anti-cancer properties apart from nisin. The bacteria exhibits direct cytotoxic effects against various cancer cell lines, including lung, colon, gastric, breast, and liver cancers, while enhancing the effectiveness of conventional treatments like chemotherapy and immunotherapy. This enhancement occurs primarily through immune system modulation, with L. lactis increasing populations of critical immune cells such as CD4+ T cells, CD8+ effector T cells, and NK cells in the spleen and tumor microenvironment. Furthermore, the bacteria produce several anti-cancer metabolites beyond nisin, including vaccenic acid, s-adenosylmethionine, and oleic acid, while helping prevent tumor growth by inhibiting cancer cell migration and angiogenesis through the reduction of key factors like VEGF and angiopoietins. These comprehensive anti-cancer mechanisms, combined with L. lactis’s established safety profile and ability to enhance existing treatments, highlight why researchers have become particularly interested in nisin and other compounds produced by this remarkable organism.

High-Ozonide Oil’s Three-Pronged Attack Against Cancer

High-ozonide oil (HOO) represents an innovative approach to cancer treatment through its multi-faceted mechanisms of generating excessive oxidative stress within cancer cells. The three key mechanisms work in concert to create a comprehensive anti-cancer effect:

1. HOO directly targets and oxidizes mitochondrial membranes in cancer cells. This targeting is selective because cancer cell mitochondria have altered membrane structures compared to healthy cells, particularly in their cardiolipin composition. When HOO interacts with these compromised mitochondrial membranes, it disrupts their integrity and triggers the release of calcium ions into the cytoplasm. This calcium release initiates apoptotic pathways that lead to programmed cell death.
2. HOO increases reactive oxygen species (ROS) production within cancer cells. Cancer cells typically maintain high levels of antioxidants to protect themselves from oxidative damage. HOO overwhelms these protective mechanisms by generating additional ROS, which creates oxidative stress that cancer cells cannot sufficiently neutralize. This particularly impacts cancer stem cells, which rely heavily on antioxidant systems for survival. By depleting these antioxidant reserves, HOO makes cancer cells and cancer stem cells more vulnerable to oxidative damage and conventional treatments like chemotherapy and radiation.
3. HOO improves oxygen availability in the tumor microenvironment. Cancer tissues are often hypoxic (low in oxygen), which triggers processes that promote tumor growth and metastasis, mainly through the activation of hypoxia-inducible factors (HIFs) that stimulate blood vessel formation. HOO counteracts this by releasing oxygen species into the tumor environment. This increased oxygen availability helps normalize the tumor microenvironment and reduces the hypoxia-driven signals that typically support cancer progression and spread.

These three mechanisms work synergistically to create a hostile environment for cancer cells while largely sparing healthy tissue. The selectivity of HOO’s effects stems from fundamental differences between cancer and normal cells, particularly in their mitochondrial function and membrane composition. This targeted approach helps explain why HOO was shown to enhance the effectiveness of standard cancer treatments while maintaining a favorable safety profile.

Synergistic Interactions

Combining nisin and HOO creates powerful synergistic effects through multiple complementary pathways to create a comprehensive anti-cancer response. This synergy operates through carefully coordinated mechanisms that target cancer cells at multiple levels while maintaining selectivity for malignant tissue. The combination creates powerful synergistic effects through various pathways:

1. Enhanced calcium dysregulation: Both agents induce intracellular calcium release through distinct mechanisms. Nisin forms membrane pores, while HOO disrupts mitochondrial calcium stores, amplifying calcium overload in cancer cells.
2. Complementary ROS generation: Nisin sensitizes cancer cells to oxidative damage by weakening membrane integrity, while HOO amplifies this effect by generating additional ROS, overwhelming cancer cell antioxidant defenses.
3. Selective targeting: Their combined specificity for cancer cells minimizes damage to healthy tissue, with nisin targeting membrane differences, while HOO exploits mitochondrial vulnerabilities unique to cancer cells.
4. Angiogenesis inhibition: Nisin’s anti-angiogenic effects complement HOO’s ability to improve oxygenation and inhibit metastatic spread by addressing hypoxia-induced pathways.

Applications and Future Prospects

Nisin and HOO have each demonstrated effectiveness against multiple cancer types and have shown promise as an adjuvant therapy alongside conventional treatments like chemotherapy and radiation, potentially allowing for reduced dosages of more toxic agents. The combination of nisin and HOO represents an exciting development in cancer therapeutics. Their complementary mechanisms and established safety profiles make them compelling candidates for future cancer treatment strategies, particularly as part of combination therapies designed to maximize therapeutic benefit while minimizing side effects. By leveraging their distinct yet complementary mechanisms, nisin and HOO present a potentially promising combination for innovative, targeted cancer therapies designed to maximize therapeutic benefit while minimizing side effects.

References

1. Azmi MF, Khateeb AA, Froemming GA, Rahim SA, Omar E. Nisin as a potential anticancer agent. Science, Engineering and Health Studies. 2021;15:21010007.
2. Hosseini SS, Hajikhani B, Goudarzi H, Rommasi F, Nasiri MJ. Cytotoxic Activity of Nisin on Human Cancer Cell Lines: A Systematic Review. Novel Biomed. 2022;10(3):184-91.
3. Izzotti A, Fracchia E, Rosano C, Comite A, Belgioia L, Sciacca S, Khalid Z, Congiu M, Colarossi C, Blanco G, Santoro A, Chiara M, Pulliero A. Efficacy of High-Ozonide Oil in Prevention of Cancer Relapses Mechanisms and Clinical Evidence. Cancers (Basel). 2022 Feb 24;14(5):1174.
4. Joo NE, Ritchie K, Kamarajan P, Miao D, Kapila YL. Nisin, an apoptogenic bacteriocin and food preservative, attenuates HNSCC tumorigenesis via CHAC1. Cancer Med. 2012 Dec;1(3):295-305.
5. Kamarajan P, Hayami T, Matte B, Liu Y, Danciu T, Ramamoorthy A, Worden F, Kapila S, Kapila Y. Nisin ZP, a Bacteriocin and Food Preservative, Inhibits Head and Neck Cancer Tumorigenesis and Prolongs Survival. PLoS One. 2015 Jul 1;10(7):e0131008.
6. Kaur S, Kaur S. Bacteriocins as Potential Anticancer Agents. Front Pharmacol. 2015 Nov 10;6:272.
7. Kim S, Kim Y, Lee S, Kim Y, Jeon B, Kim H, Park H. Live Biotherapeutic Lactococcus lactis GEN3013 Enhances Antitumor Efficacy of Cancer Treatment via Modulation of Cancer Progression and Immune System. Cancers (Basel). 2022 Aug 23;14(17):4083.
8. Molujin AM, Abbasiliasi S, Nurdin A, Lee PC, Gansau JA, Jawan R. Bacteriocins as Potential Therapeutic Approaches in the Treatment of Various Cancers: A Review of In Vitro Studies. Cancers (Basel). 2022 Sep 29;14(19):4758.
9. Niamah AK, Al-Sahlany STG, Verma DK, Shukla RM, Patel AR, Tripathy S, Singh S, Baranwal D, Singh AK, Utama GL, Chávez González ML, Alhilfi WAH, Srivastav PP, Aguilar CN. Emerging lactic acid bacteria bacteriocins as anti-cancer and anti-tumor agents for human health. Heliyon. 2024 Aug 29;10(17):e37054.
10. Sadri H, Aghaei M, Akbari V. Nisin induces apoptosis in cervical cancer cells via reactive oxygen species generation and mitochondrial membrane potential changes. Biochem Cell Biol. 2022 Apr;100(2):136-141.
11. Zhang QY, Yan ZB, Meng YM, Hong XY, Shao G, Ma JJ, Cheng XR, Liu J, Kang J, Fu CY. Antimicrobial peptides: mechanism of action, activity and clinical potential. Mil Med Res. 2021 Sep 9;8(1):48.